Market Place
Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified. 
X
Please Wait
Applying Filters...
01 BLOOMAGE BIOTECHNOLOGY CORP., LTD. Jinan CN (11)
02 KEWPIE CORPORATION Tokyo JP (2)
03 HTL Javené FR (3)
04 HTL S.A.S. Javené FR (1)
05 ALTERGON ITALIA S.R.L. Milano IT (1)
06 AMHWA BIOPHARM CO., LTD. Binzhou CN (3)
07 Bio-Technology General (Israel) Ltd. Kiryat Malachi IL (1)
08 Contipro Cas Usti Nad Orlici CZ (1)
09 Contipro a.s. Dolní Dobrouč CZ (2)
10 FIDIA FARMACEUTICI S.P.A. Abano Terme IT (3)
11 Fidia Farmaceutici S.p.A. Abano Terme IT (4)
12 KIKKOMAN BIOCHEMIFA COMPANY Noda City JP (4)
13 LG CHEM, LTD. Seoul KR (1)
14 Lifecore Biomedical, LLC Chaska US (2)
15 MARUHA NICHIRO CORPORATION Utsunomiya JP (1)
16 MEIJI SEIKA PHARMA CO., LTD. Tokyo JP (1)
17 SHANDONG FOCUSFREDA BIOTECH CO., LTD. Qufu CN (1)
18 SHANDONG TOPSCIENCE BIOTECH CO., LTD. Rizhao CN (4)
19 SHISEIDO CO., LTD. Tokyo JP (1)
01 Sodium hyaluronate, Alternative process, not less than 1.6m3/kg, by fermentation, for parenteral administration including intra-articular administration, and for intra-ocular use. (1)
02 Sodium hyaluronate, Alternative process; Intrinsic viscosity : less than 1.8 m3/kg, by fermentation, for parenteral and ophthalmic administration including intra-articular use and intra-ocular use (1)
03 Sodium hyaluronate, GS-100, intrinsic viscosity: 1.50 m3/kg; from fermentation; for parenteral administration, including intra-ocular use (1)
04 Sodium hyaluronate, GS-120, intrinsic viscosity: 1.7 m3/kg; from fermentation; for parenteral administration, including intra-ocular use (1)
05 Sodium hyaluronate, GS-200; intrinsic viscosity 2.77 m3/kg; from fermentation; for parenteral administration, including intra-ocular use (1)
06 Sodium hyaluronate, Grade 80; intrinsic viscosity 1.70 m3/kg; from fermentation, for parenteral administration, including intra-ocular use (1)
07 Sodium hyaluronate, HA-E2.0 (intrinsic viscosity 1.2-2.8 m3/kg), from fermentation, for parenteral administration other than intra-articular administration and intra-ocular use (1)
08 Sodium hyaluronate, HA-E3.0 (intrinsic viscosity 2.7-3.6 m3/kg), from fermentation, for parenteral administration other than intra-articular administration and intra-ocular use (1)
09 Sodium hyaluronate, HA-EP 1.8 (intrinsic viscosity: 1.6-2.2 m3/kg); from fermentation; for parenteral administration including intra-articular administration and intra-ocular use (1)
10 Sodium hyaluronate, HA-EP 3.0 (intrinsic viscosity: 2.7-3.6 m3/kg); from fermentation; for parenteral administration including intra-articular administration and intra-ocular use (1)
11 Sodium hyaluronate, Intrinsic viscosity 0.2 to 2.4 m3/kg; by fermentation; for parenteral administration and for intra-ocular and intra-articular use (1)
12 Sodium hyaluronate, Intrinsic viscosity 0.2-3.2 m3/kg, by fermentation, for parenteral administration including intra-articular administration and intra-ocular use (1)
13 Sodium hyaluronate, Intrinsic viscosity 0.6 m3/kg and 0.8 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
14 Sodium hyaluronate, Intrinsic viscosity 1.25 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
15 Sodium hyaluronate, Intrinsic viscosity 1.28 m3/kg; 1.63 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
16 Sodium hyaluronate, Intrinsic viscosity 1.4 m3/kg and 1.0 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
17 Sodium hyaluronate, Intrinsic viscosity 1.8 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
18 Sodium hyaluronate, Intrinsic viscosity 2.12 m3/kg, from fermentation, for parenteral administration, including intra-articular administration, and for intra-ocular use (1)
19 Sodium hyaluronate, Intrinsic viscosity 2.3 m3/kg, by fermentation, for parenteral administration other than intra-articular administration and intra-ocular use (1)
20 Sodium hyaluronate, Intrinsic viscosity 2.4 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
21 Sodium hyaluronate, Intrinsic viscosity 2.5 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
22 Sodium hyaluronate, Intrinsic viscosity 2.7-3.6 m3/kg, by fermentation, for parenteral administration including intra-articular and intra-ocular use (1)
23 Sodium hyaluronate, Intrinsic viscosity 2.93 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
24 Sodium hyaluronate, Intrinsic viscosity 3.0-4.0 m3/kg, by fermentation, for parenteral administration including intra-articular use and for intra-ocular use (1)
25 Sodium hyaluronate, Intrinsic viscosity 3.4 m3/kg, by fermentation, sterile, for intra-ocular use (1)
26 Sodium hyaluronate, Intrinsic viscosity 3.8 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
27 Sodium hyaluronate, Intrinsic viscosity ranges: 0.3-0.9 m3/kg, 1.0-2.3 m3/kg and 1.8-3.1 m3/kg; by fermentation; for parenteral administration and for intra-ocular and intra-articular use after appropriate sterilisation (1)
28 Sodium hyaluronate, Intrinsic viscosity ranges: 2.2-3.0 m3/Kg, 1.8-2.5 m3/Kg, 1.4-1.9 m3/Kg, 1.1-1.5 m3/Kg; from fermentation; for parenteral administration, including intra-articular administration and intra-ocular use (1)
29 Sodium hyaluronate, Intrinsic viscosity: 0.3 - 0.6 m3/kg, by fermentation, for cutaneous use (1)
30 Sodium hyaluronate, Intrinsic viscosity: 0.5 m3/kg; 0.83 m3/kg and 1.25 m3/kg; from fermentation; for cutaneous and parenteral administration, including intra-articular administration, and for intra-ocular use. (1)
31 Sodium hyaluronate, Intrinsic viscosity: 0.5 m3/kg; 1.25 m3/kg; 2.0 m3/kg; 2.67 m3/kg; from fermentation; for cutaneous and parenteral administration, including intra-articular administration, and for intra-ocular use. (1)
32 Sodium hyaluronate, Intrinsic viscosity: 1.0-1.5 m3/kg, by fermentation, for intra-articular use (1)
33 Sodium hyaluronate, Intrinsic viscosity: 1.5 - 1.9 m3/kg; by fermentation; for parenteral administration, including intra-ocular and intra-articular administration (1)
34 Sodium hyaluronate, Intrinsic viscosity: 1.6 m3/kg; 2.0 m3/kg and 2.5 m3/kg; from fermentation; for cutaneous and parenteral administration, including intra-articular administration, and for intra-ocular use. (1)
35 Sodium hyaluronate, Intrinsic viscosity: 1.62m3/kg - 1.70m3/kg and 2.28m3/kg - 3.78m3/kg; from fermentation; for parenteral administration, including intra-articular administration and intra-ocular use (1)
36 Sodium hyaluronate, Intrinsic viscosity: 1.7 m3/kg, 1.9 m3/kg, 2.4 m3/kg, 2.8 m3/kg, or 3.5 m3/kg, by fermentation, for parenteral administration including intra-articular use and intra-ocular use (1)
37 Sodium hyaluronate, Intrinsic viscosity: 1.7-2.1 m3/kg, by fermentation, for intra-ocular use (1)
38 Sodium hyaluronate, Intrinsic viscosity: 2.0-3.4 m3/kg, from fermentation; for parenteral administration, including intra-articular administration, and for intra-ocular use (1)
39 Sodium hyaluronate, Intrinsic viscosity: 2.93 m3/kg, from fermentation, for parenteral administration, including intra-articular administration, and for intra-ocular use (1)
40 Sodium hyaluronate, Intrinsic viscosity: more than 2.5 m3/kg, by fermentation, for parenteral administration including intra-ocular administration and for intra-ocular use (1)
41 Sodium hyaluronate, Intrinsic viscosity: not less than 0.65 m3/kg; by fermentation, for parenteral administration including intra-articular use and intra-ocular use (1)
42 Sodium hyaluronate, SH 1.3; intrinsic viscosity 1.3 m3/kg, from fermentation; for parenteral administration including intra-articular administration and intra-ocular use (1)
43 Sodium hyaluronate, SH 2.2; intrinsic viscosity 2.2 m3/kg, from fermentation; for parenteral administration including intra-articular administration and intra-ocular use (1)
44 Sodium hyaluronate, SH 3.0; intrinsic viscosity 3.0 m3/kg, from fermentation; for parenteral administration including intra-articular administration and intra-ocular use (1)
45 Sodium hyaluronate, Type II (intrinsic viscosity: not higher than 0.70 m3/kg), from fermentation, for parenteral administration including intra-articular administration and intra-ocular use (1)
46 Sodium hyaluronate, intrinsic viscosity 1.55 m3/kg, by fermentation, for parenteral administration including intra-articular administration and for intra-ocular use (1)
47 Sodium hyaluronate, intrinsic viscosity 1.66 m3/kg, 2.27 m3/kg, 3.30 m3/kg; from fermentation; for parenteral administration including intra-articular administration and intra-ocular use (1)
01 China (19)
02 Czech Republic (3)
03 France (4)
04 Israel (1)
05 Italy (7)
06 Japan (8)
07 South Korea (1)
08 U.S.A (3)
09 Blank (1)
01 Expired (1)
02 Valid (46)
68
PharmaCompass offers a list of Sodium Hyaluronate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Hyaluronate manufacturer or Sodium Hyaluronate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Hyaluronate manufacturer or Sodium Hyaluronate supplier.
PharmaCompass also assists you with knowing the Sodium Hyaluronate API Price utilized in the formulation of products. Sodium Hyaluronate API Price is not always fixed or binding as the Sodium Hyaluronate Price is obtained through a variety of data sources. The Sodium Hyaluronate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Hyaluronate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Hyaluronate, including repackagers and relabelers. The FDA regulates Sodium Hyaluronate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Hyaluronate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Hyaluronate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Hyaluronate supplier is an individual or a company that provides Sodium Hyaluronate active pharmaceutical ingredient (API) or Sodium Hyaluronate finished formulations upon request. The Sodium Hyaluronate suppliers may include Sodium Hyaluronate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Hyaluronate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Hyaluronate CEP of the European Pharmacopoeia monograph is often referred to as a Sodium Hyaluronate Certificate of Suitability (COS). The purpose of a Sodium Hyaluronate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium Hyaluronate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium Hyaluronate to their clients by showing that a Sodium Hyaluronate CEP has been issued for it. The manufacturer submits a Sodium Hyaluronate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium Hyaluronate CEP holder for the record. Additionally, the data presented in the Sodium Hyaluronate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium Hyaluronate DMF.
A Sodium Hyaluronate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium Hyaluronate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium Hyaluronate suppliers with CEP (COS) on PharmaCompass.
We have 15 companies offering Sodium Hyaluronate
Get in contact with the supplier of your choice:
